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EDITORIAL
Endobronchial  ultrasound  in  sarcoidosis:  Time
to rethink  the  diagnostic  strategy?
Ecoendoscopia  brônquica  na  sarcoidose:  é  tempo  de  repensar  a  estratégiad
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Currently  the  diagnosis  of  pulmonary  sarcoidosis  is  shif-
ting  from  conventional  bronchoscopy  procedures  to  other
minimally  invasive  techniques,  which  are  safer  and  more
effective.  In  this  issue  of  the  Portuguese  Journal  of  Pul-
monology,  Ribeiro  C  and  co-authors  prospectively  evaluated
39  patients  with  suspected  sarcoidosis  (stages  I  or  II)  and
obtained  94%  diagnostic  yield  based  on  EBUS-TBNA  ﬁndings,
without  complications.1 These  results  are  in  line  with  cur-
rent  international  literature  and  certainly  reﬂect  the  value
of  the  technique  in  experienced  hands.
Sarcoidosis  is  the  most  prevalent  interstitial  lung  disease
in  Europe  and  in  the  United  States  and  is  characterized  by
accumulation  of  non-caseating  granulomas  in  tissue.  Though
it  may  involve  virtually  every  organ,  it  affects  the  lungs
and  intrathoracic  lymph  nodes  in  90%  of  cases.  Diagnosis
is  usually  initially  based  on  clinical  and  radiological  sus-
picion  but  tissue  conﬁrmation  is  strongly  recommended  in
order  to  exclude  diseases  of  similar  presentation,  such  as
tuberculosis,  fungal  infections,  lymphoma  and  even  lung
cancer.  In  clinical  practice,  the  vast  majority  of  patients
referred  for  the  evaluation  of  pulmonary  sarcoidosis  present
stages  I  or  II.  In  the  absence  of  easily  accessible  biopsy  sites
(skin  or  superﬁcial  lymph  nodes)  for  the  current  diagnostic
work-up,  conventional  ﬂexible  bronchoscopy  endobronchial
biopsy  (EBB)  and  transbronchial  lung  biopsy  (TBLB)  are
recommended,  however,  their  sensitivity  in  detecting  gran-
ulomas  is  moderate  even  when  they  are  combined.  Moreover
TBLB  may  be  associated  with  serious  adverse  events  such  as
pneumothorax  and  hemoptysis.  In  cases  of  enlarged  medi-
astinal  or  hilar  lymph  nodes  an  additionally  ‘‘semi-blind’’
transbronchial  needle  aspiration  (TBNA),  guided  by  previous
CT  scans,  is  able  to  increase  diagnostic  yield,  especially  if
puncture  is  performed  in  subcarinal  and  right  paratracheal
stations,  but  this  technique  is  highly  operator-dependent.
Bronchoalveolar  lavage  (BAL)  ﬁndings  such  as  lymphocytosis
in  combination  with  a  CD4+/CD8+  ratio  >3.5  are  considered
helpful  for  the  ﬁnal  diagnosis  but  are  very  variable.  If  the
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ndings,  more  invasive  and  expensive  surgical  procedures
uch  as  mediastinoscopy  (MS)  or  video  assisted  thoracic
urgery  (VATS)  lung  biopsy  may  be  required.
In  the  XXI  century,  tissue  proof  of  non-caseating
ranulomas  can  instead  be  obtained  by  sampling  intratho-
acic  lymph  nodes  under  real-time  ultrasound  guidance.
ndobronchial  ultrasound-guided  transbronchial  needle
spiration  (EBUS-TBNA)  and  transesophageal  ultrasound-
uided  ﬁne-needle  aspiration  (EUS-FNA)  are  complimentary
echniques  regarding  their  diagnostic  reach  in  combination.
irtually  they  can  reach  all  hilar,  interlobar  and  mediastinal
ymph  nodes  including  paratracheal,  subcarinal  and  paraoe-
ophageal  stations.  The  decision  to  perform  either  EUS
r  EBUS  is  usually  left  to  the  local  endoscopist  and  may
epend  on  availability  of  equipment,  CT  ﬁndings  or  the
reference  of  either  physician  or  patient.  In  2009,  a  ran-
omized  controlled  trial2 showed  that  EBUS-TBNA  improved
he  diagnostic  sensitivity  by  22%  compared  to  conventional
BNA  and  in  2013  a  frequently  cited  study  proved  that  the
iagnostic  yield  of  EBUS/EUS  (80%)  was  better  than  bron-
hoscopy  (53%).3 These  results  agree  with  a meta-analysis
hat  revealed  a pooled  accuracy  of  EBUS-TBNA  of  80%  in
arcoidosis  (range  54--93%).4
Therefore,  head-to-head  comparisons  between  conven-
ional  techniques  and  EBUS-TBNA/EUS-FNA  in  sarcoidosis
ave  proved  that  endosonography  is  superior  and  it  is
xpected  that  in  the  near  future  it  will  become  the  primary
iagnostic  tool  in  patients  suspected  of  stage  I/II  sarcoidosis.
ith  the  growing  experience  of  pathologists  the  demon-
tration  of  non-caseating  epithelioid  granulomas  based  on
ytological  material  is  feasible  and  reliable.  Some  authors
ave  pointed  out  the  need  to  obtain  histological  core  tis-
ue  biopsies  with  a  19-gauge  needle  because  histological
valuation  is  more  reliable  in  excluding  lymphoproliferative
isorders  and  tuberculosis  (at  present  19-gauge  needles  are
vailable  only  for  conventional  TBNA  and  EUS).
lsevier España, S.L.U. All rights reserved.
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One  may  wonder  if  every  bronchoscopy  unit  all  over  the
orld  should  invest  in  echoendoscopes  and  if  conventional
rocedures  have  already  become  redundant  in  the  diagno-
is  of  sarcoidosis.  Flexible  bronchoscopy  still  seems  to  have
ome  advantages  because  it  is  a  widely  available  diagnostic
ool.  A  single  scope  can  be  used  for  the  entire  procedure
nabling  several  sampling  techniques.  It  is  quite  easy  to
earn  to  use  and  is  also  maneuverable  with  optimal  endo-
ronchial  image  for  the  majority  of  bronchoscopists.  Finally,
tandard  ﬂexible  video  bronchoscopes  are  less  expensive
s  well  as  more  robust  compared  to  the  echoendoscopes.
n  addition,  some  of  the  published  endosonography  trials
ave  design  problems  such  as,  patient  selection  bias;  the
ajority  of  lymph  nodes  were  sampled  in  bulky  stations
R  and  7  that  are  easily  sampled  by  ‘‘semi-blind’’  TBNA
ith  comparable  yield;  and  others  have  been  criticized  due
o  the  exclusion  of  conventional  TBNA  in  the  bronchoscopy
roup.3 Two  recent  studies  have  conﬁrmed  the  importance
f  conventional  procedures  in  the  diagnosis  of  sarcoidosis.
irstly,  a  systematic  review  and  meta-analysis5 has  shown
hat  conventional  TBNA  has  a  pooled  efﬁcacy  of  62%  in  sar-
oidosis,  without  any  major  complications,  and  when  TBNA
nd  TBLB  are  combined  the  diagnostic  yield  increases  to  83%,
imilar  to  EBUS/EUS-FNA.  And  secondly,  a  well-designed  ran-
omized  controlled  trial6 has  demonstrated  that  individually
BUS-TBNA  has  the  highest  diagnostic  yield  (74.5%)  and  this
s  even  better  when  combined  with  TBLB  (90.9%)  but  the
iagnostic  yield  of  ‘‘semi-blind’’  TBNA  plus  EBB  and  TBLB
llows  comparable  results  (85.5%,  p  >  0.05).
In  conclusion,  those  who  do  not  have  EBUS/EUS  or  can-
ot  refer  the  patient  to  a  center  with  this  equipment  still
ave  a  good  chance  to  diagnose  sarcoidosis  by  optimizing
nd  combining  conventional  techniques.
So,  is  EBUS-TBNA  the  best  tool  available  to  diagnose  pul-
onary  sarcoidosis?  Yes,  it  is.  Is  it  the  only  tool?  No,  of  course
ot!EDITORIAL
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